Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Cites (326)

Items 201–326 of 326

1. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes
   Denusa Wiltgen, Poli Mara Spritzer · 2010 · Fertility and Sterility
2. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome
   Anthony P. Cheung · 2001 · Obstetrics and Gynecology
3. Cognitive–behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study
   Rofey, D. L., Szigethy, E. M., Noll, R. B., Dahl, R. E., lobst, E., Arslanian, S. A. · 2008 · Journal of Pediatric Psychology
4. Longitudinal Change of Sonographic Ovarian Aspects and Endocrine Parameters in Irregular Cycles of Adolescence
   Stefano Venturoli, Eleonora Porcu, Raffaella Fabbri, Valeria Pluchinotta, Saverio Ruggeri, S. Macrelli, Roberto Paradisi, C Flamigni · 1995 · Pediatric Research
5. Functional Significance of Polycystic-Size Ovaries in Healthy Adolescents
   Mortensen, Monica, Rosenfield, Robert L., Littlejohn, Elizabeth · 2006 · The Journal of Clinical Endocrinology & Metabolism
6. Psychological well-being and sexarche in women with polycystic ovary syndrome
   de Niet, J. E., de Koning, C. M., Pastoor, H., Duivenvoorden, H. J., Valkenburg, O., Ramakers, M. J., Passchier, J., de Klerk, C., Laven, J. S. E. · 2010 · Human Reproduction
7. Lipid and apolipoprotein abnormalities in hirsute women
   Robert A. Wild, Petar Alaupovic, Ivy J. Parker · 1992 · American Journal of Obstetrics and Gynecology
8. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome
   Robert John Norman, S Mahabeer, Stacey C. Masters · 1995 · Fertility and Sterility
9. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study
   Seija Korhonen, Maritta Hippeläinen, Mauno J. Vanhala, Seppo T Heinonen, LEO K. NISKANEN · 2003 · Fertility and Sterility
10. The Effect of a Desogestrel-Containing Oral Contraceptive on Glucose Tolerance and Leptin Concentrations in Hyperandrogenic Women
    Shahla Nader, Maggy G. Riad, Mohammed F. Saad · 1997 · The Journal of Clinical Endocrinology & Metabolism
11. Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy
    Glueck, Charles J., Dharashivkar, Swapna, Wang, Ping, Zhu, Binghua, Gartside, Peter S., Tracy, Trent, Sieve, Luann · 2005 · European Journal of Obstetrics & Gynecology and Reproductive Biology
12. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Küster-Hauser syndrome
    Laggari, Varvara, Diareme, Stavroula, Christogiorgos, Stylianos, Deligeoroglou, Efthimios, Christopoulos, Panagiotis, Tsiantis, John, Creatsas, George · 2009 · Journal of Psychosomatic Obstetrics & Gynecology
13. Update and Future of Hormonal Therapy in Acne
    Diane M. Thiboutot, WenChieh Chen · 2003 · Dermatology
14. <i>Polycystic Ovary Syndrome in Adolescence</i>
    Blank, Susan K., Helm, Kristin D., McCartney, Christopher R., Marshall, John C. · 2008 · Annals of the New York Academy of Sciences
15. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women
    Maria Augusta Maturana, Vitor Breda, Francisco Luiz Rodrigues Lhullier, Poli Mara Spritzer · 2008 · Metabolism
16. Clinical expression of polycystic ovary syndrome in adolescent girls
    Sultan, Charles, Paris, Françoise · 2006 · Fertility and Sterility
17. The Lived Experience of Women Diagnosed With Polycystic Ovary Syndrome
    Barbara S Snyder · 2006 · Journal of Obstetric, Gynecologic & Neonatal Nursing
18. Predictors of Pregnancy in Women with Polycystic Ovary Syndrome
    Mary Rausch, Richard S. Legro, Huiman Xie Barnhart, William D. Schlaff, Bruce Richard Carr, Michael P. Diamond, Sandra Ann Carson, Michael P. Steinkampf, Peter G. McGovern, Nicholas A. Cataldo et al. · 2009 · The Journal of Clinical Endocrinology & Metabolism
19. Bone Mineral Density, Androgens, and the Polycystic Ovary: The Complex and Controversial Issue of Androgenic Influence in Female Bone
    Zborowski, Jeanne V., Cauley, Jane A., Talbott, Evelyn O., Guzick, David S., Winters, Stephen J. · 2000 · The Journal of Clinical Endocrinology &amp; Metabolism
20. Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
    Stephen Franks, Lisa J. Webber, Micaela J. Goh, Anne Valentine, Davinia M. White, Gerard S. Conway, Steven Wiltshire, Mark I. McCarthy · 2008 · The Journal of Clinical Endocrinology & Metabolism
21. The Relationship between Clinico-Biochemical Characteristics and Psychiatric Distress in Young Women with Polycystic Ovary Syndrome
    Ertan Adalı, Recep Yıldızhan, Mertihan Kurdoğlu, Ali Kolusarı, Tamer Edirne, H. Güler Şahin, Begüm Yıldızhan, Mansur Kamacı · 2008 · Journal of International Medical Research
22. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
    Mithat Erenus, Deniz Yücelten, Fatih Durmuşoğlu, Oya Gürbüz · 1997 · Fertility and Sterility
23. Lack of association between polycystic ovary syndrome and embryonic aneuploidy
    Andrea Weghofer, S. Munné, Serena Chen, David H. Barad, Norbert Gleicher · 2007 · Fertility and Sterility
24. Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 U.S. Case-Control Studies. VI. Nonepithelial Cancers among Adults
    Pamela L. Horn‐Ross, Alice S. Whittemore, Robin B. Harris · 1992 · Epidemiology
25. Adolescent Female Acne: Etiology and Management
    Yetunde Olutunmbi, Kristina Paley, Joseph C. English · 2008 · Journal of Pediatric and Adolescent Gynecology
26. Metabolic syndrome in young Czech women with polycystic ovary syndrome
    Jana Vrbíková, K Vondra, David Cibula, K. Dvořáková, Soňa Stanická, D. Šrámková, G Šindelka, Martin Hill, Běla Bendlová, Jan Škrha · 2005 · Human Reproduction
27. Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome.
    Agnieszka Barbara Drosdzol-Cop, Violetta Skrzypulec, Beata Mazur, Romana Pawliñska-Chmara · 2007 · PubMed
28. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Chandrika N. Wijeyaratne, Krishnarajah Nirantharakumar, Adam H. Balen, Julian H. Barth, Rezvi Sheriff, Paul E. Belchetz · 2004 · Clinical Endocrinology
29. Body Fat Distribution in Women With Polycystic Ovary Syndrome
    Tsutomu Douchi · 1995 · Obstetrics and Gynecology
30. Dermatology of androgen-related disorders
    Paulina A. Essah, Edmond P. Wickham, Julia R. Nunley, John E. Nestler · 2006 · Clinics in Dermatology
31. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles
    Mariet W. Elting, Janet Kwee, Ted J. M. Korsen, Lyset T. M. Rekers-Mombarg, Joop Schoemaker · 2003 · Fertility and Sterility
32. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Gustavo Mafaldo Soares, Carolina Sales Vieira, Wellington P. Martins, Sílvio Antônio Franceschini, Rosana Maria dos Reis, Marcos Felipe Silva de Sá, Rui Alberto Ferriani · 2008 · Clinical Endocrinology
33. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients
    T. Strowitzki, Edison Capp, Helena von Eye Corleta · 2010 · European Journal of Obstetrics & Gynecology and Reproductive Biology
34. Prospective follow‐up of menstrual disorders in adolescence and prognostic factors
    WIKSTEN‐ALMSTRÖMER, MARIANNE, HIRSCHBERG, ANGELICA LINDÉN, HAGENFELDT, KERSTIN · 2008 · Acta Obstetricia et Gynecologica Scandinavica
35. Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women
    V. Kumarapeli, R. d. A. Seneviratne, CN Wijeyaratne · 2010 · BJOG An International Journal of Obstetrics & Gynaecology
36. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
    R. Koivunen, Anneli M. Pouta, Stephen Franks, Hannu K. Martikainen, Ulla Sovio, A‐L Hartikainen, Mark I. McCarthy, Aimo Ruokonen, Aini H. Bloigu, Marjo‐Riitta Järvelin et al. · 2008 · Human Reproduction
37. Orchestration of Glucose Homeostasis
    R. Bergman · 2007 · Diabetes
38. Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism
    Richard Charles O’Brien, M. E. COOPER, Richard Murray, Ego Seeman, Anya Thomas, G. Jerums · 1991 · The Journal of Clinical Endocrinology & Metabolism
39. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation
    C. Noel Bairey Merz, B. Delia Johnson, Sarah L. Berga, Glenn David Braunstein, Steven E. Reís, Vera Bittner · 2006 · Fertility and Sterility
40. Progestogen deficiency and endometrial cancer risk
    Adolf Eduard Schindler · 2009 · Maturitas
41. Nurse‐led peer support group: experiences of women with polycystic ovary syndrome
    Carol A. Percy, Tineke Gibbs, Lj Potter, Shirine Boardman · 2009 · Journal of Advanced Nursing
42. Menstrual Irregularities in Adolescents: Hormonal Pattern and Ovarian Morphology
    Venturoli, S., Porcu, E., Fabbri, R., Paradisi, R., Ruggeri, S., Bolelli, G., Orsini, L.F., Gabbi, D., Flamigni, C. · 2008 · Hormone Research
43. Not all women diagnosed with PCOS share the same cardiovascular risk profiles
    Vuk P. Jovanovic, Enrico Carmina, Rogerio A. Løbo · 2009 · Fertility and Sterility
44. Appropriate BMI levels for PCOS patients in Southern China
    Xingfei Chen, R. Ni, Ying‐Qian Mo, Lei Li, Dongzi Yang · 2010 · Human Reproduction
45. Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome
    Stephanie E. Harris, Deivanayagam Maruthini, T. Tang, Adam H. Balen, Helen Mary Picton · 2010 · Human Reproduction
46. PCOS, Sexuality, and Clitoral Vascularisation: A Pilot Study
    Cesare Battaglia, Rossella Elena Nappi, Fulvia Mancini, Arianna Cianciosi, Nicola Persico, Paolo Busacchi, Fabio Facchinetti, Giovanni Sisti · 2008 · The Journal of Sexual Medicine
47. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin
    Harris-Glocker, Miranda, Davidson, Kristin, Kochman, Lynda, Guzick, David, Hoeger, Kathleen · 2010 · Fertility and Sterility
48. Epigenetic abnormality: A possible mechanism underlying the fetal origin of polycystic ovary syndrome
    Zhongxiang Li, Hefeng Huang · 2007 · Medical Hypotheses
49. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome
    Susanne M. Veltman-Verhulst, Timon W. van Haeften, Marinus J.C. Eijkemans, Harold W. de Valk, Bart C.J.M. Fauser, Angelique J. Goverde · 2010 · Human Reproduction
50. Epigenetic Modification of the X Chromosome Influences Susceptibility to Polycystic Ovary Syndrome
    Theresa E. Hickey, Richard S. Legro, Robert John Norman · 2006 · The Journal of Clinical Endocrinology & Metabolism
51. Reproductive endocrinology of adolescent polycystic ovary syndrome
    Rana F. Shayya, R. Jeffrey Chang · 2009 · BJOG An International Journal of Obstetrics & Gynaecology
52. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States
    Pamela J. Schwingl, Howard W. Ory, Cynthia M. Visness · 1999 · American Journal of Obstetrics and Gynecology
53. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes
    Stefano Palomba, Angela Immacolata Falbo, Tiziana Russo, Lucia Battista, Achille Tolino, Francesco Orio, Fulvio Zullo · 2010 · BJOG An International Journal of Obstetrics & Gynaecology
54. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome
    Aykan Yücel, Volkan Noyan, Nevin Sağsöz · 2005 · European Journal of Obstetrics & Gynecology and Reproductive Biology
55. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
    Xiaomiao Zhao, Junmin Zhong, Yaqin Mo, Xiaoli Chen, Yaxiao Chen, Dongzi Yang · 2009 · International Journal of Gynecology & Obstetrics
56. Polycystic Ovary Syndrome: Early Detection in the Adolescent
    R. Jeffrey Chang, Mickey S. Coffler · 2007 · Clinical Obstetrics & Gynecology
57. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome
    Moran, Lisa J., Hutchison, Samantha K., Meyer, Caroline, Zoungas, Sophia, Teede, Helena J. · 2009 · Clinical Science
58. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria
    Sawaek Weerakiet, Pongamon Bunnag, Bunyong Phakdeekitcharoen, Surapee Wansumrith, Suwannee Chanprasertyothin, Rattiya Jultanmas, Ammarin Thakkinstian · 2007 · Gynecological Endocrinology
59. Evidence for Association between Polycystic Ovary Syndrome (PCOS) andTCF7L2and Glucose Intolerance in Women with PCOS andTCF7L2
    Assel Biyasheva, Richard S. Legro, Andrea Elizabeth Dunaif, Margrit Urbanek · 2009 · The Journal of Clinical Endocrinology & Metabolism
60. Risks and management of obesity in pregnancy: current controversies
    Joseph R. Wax · 2009 · Current Opinion in Obstetrics & Gynecology
61. Characteristics of Adolescents Presenting to a Multidisciplinary Clinic for Polycystic Ovarian Syndrome
    M. Tracy Bekx, Ellen Lancon Connor, David B. Allen · 2009 · Journal of Pediatric and Adolescent Gynecology
62. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
    Evelyn O. Talbott · 2008 · Vascular Health and Risk Management
63. Greater Arterial Stiffness in Polycystic Ovary Syndrome (PCOS) Is an Obesity- But Not a PCOS-Associated Phenomenon
    Iris J. G. Ketel, Coen D.A. Stehouwer, Ronald M.A. Henry, Erik H. Serné, Peter G.A. Hompes, Roy Homburg, Yvo Michiel Smulders, Cornelis Bavo Lambalk · 2010 · The Journal of Clinical Endocrinology & Metabolism
64. Effects of long‐term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome
    Leopoldo Falsetti, Edda Pasinetti · 1995 · Acta Obstetricia Et Gynecologica Scandinavica
65. Clinical and metabolic features of polycystic ovary syndrome
    Lin Li, Dongzi Yang, Xiaoli Chen, Yaxiao Chen, Shuying Feng, Liangan Wang · 2007 · International Journal of Gynecology & Obstetrics
66. Endocrine and Metabolic Abnormalities in Adolescents with a PCOS-like Condition: Consequences for Adult Reproduction
    Apter, Dan · 1998 · Trends in Endocrinology &amp; Metabolism
67. Polycystic ovaries in pre and post‐menopausal women
    Mary Ann Birdsall, Cindy M. Farquhar · 1996 · Clinical Endocrinology
68. Growth hormone substitution in adult growth hormone‐deficient men augments androgen effects on the skin
    G.J. Blok, Hans de Boer, Louis J. Gooren, Eduard A van der Veen · 1997 · Clinical Endocrinology
69. Obesity and Polycystic Ovary Syndromea
    Stephen Franks, Deborah S. Kiddy, Patrick S. Sharp, Anita Singh, Michael J. Reed, Markku T. Seppälä, Riitta A. Koistinen, Diana Hamilton‐Fairley · 1991 · Annals of the New York Academy of Sciences
70. Obesity-Related Lipid Profile and Altered Insulin Incretion in Adolescents With Polycystic Ovary Syndrome
    Anna Maria Fulghesu, Roberta Magnini, Elaine Portoghese, Stefano L. Angioni, Luigi Minerba, Gian Benedetto Melis · 2010 · Journal of Adolescent Health
71. Thyroid hormone and hair growth
    Andrew Guy Messenger · 2000 · British Journal of Dermatology
72. Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
    Anuja Dokras, Dinesh H. Jagasia, Michelle Maifeld, Christine A. Sinkey, Bradley J. Van Voorhis, William Geoffrey Haynes · 2006 · Fertility and Sterility
73. Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study
    Dimitrios Kassanos, Eftichios Trakakis, Christos S. Baltas, Olympia Papakonstantinou, George Simeonidis, George Salamalekis, I. Grammatikakis, Georgios Basios, George Labos, Grigoris Skarantavos et al. · 2010 · Human Reproduction
74. Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study
    Cesare Battaglia, Fulvia Mancini, Raffaella Fabbri, Nicola Persico, Paolo Busacchi, Fabio Facchinetti, Stefano Venturoli · 2009 · Fertility and Sterility
75. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism
    Susanne Hahn, Manuel Backhaus, Martina Broecker‐Preuss, Susanne Tan, Tiina Dietz, Rainer Kimmig, Markus Schmidt, Klaus Mann, Onno Eilard Janssen · 2007 · European Journal of Endocrinology
76. Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment
    Bülent Okan Yıldız · 2008 · Seminars in Reproductive Medicine
77. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
    Thomas H. Tang, Jonathan M Lord, Robert John Norman, Ephia Yasmin, Adam H. Balen · 2009 · Cochrane Database of Systematic Reviews
78. Polycystic Ovary Syndrome, Depression, and Affective Disorders
    Suzette C. Bishop, Samuel Basch, Walter Futterweit · 2009 · Endocrine Practice
79. Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome
    Waleed G. Tamimi, Imran Siddiqui, Hani Tamim, Nada AlEisa, Maysoon Adham · 2009 · International Journal of Gynecology & Obstetrics
80. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome
    Mariet W. Elting, Ted J. M. Korsen, Joop Schoemaker · 2001 · Clinical Endocrinology
81. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
    Robert P. Kauffman, Vicki M. Baker, Pamela DiMarino, V. Daniel Castracane · 2006 · Fertility and Sterility
82. Oligoovulatory and Anovulatory Cycles in Women with Polycystic Ovary Syndrome (PCOS): What’s the Difference?
    J.A. Burgers, Sharon Lie Fong, Yvonne V. Louwers, Olivier Valkenburg, Frank H. de Jong, Bart C.J.M. Fauser, Joop S.E. Laven · 2010 · The Journal of Clinical Endocrinology & Metabolism
83. Hirsutism in Saudi females of reproductive age : A hospital-based study
    Atallah D Al-Ruhaily, Usman Hammawa Malabu, Riad Abbas Sulimani · 2008 · Annals of Saudi Medicine
84. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism
    Ta-Chin Lin, Jui-Mei Yen, Kum-Bing Gong, Tsung‐Cheng Kuo, Dong-Chi Ku, Shufen Liang, Ming‐Jiuan Wu · 2006 · BMC Medical Genetics
85. Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders
    Liliane Diefenthaeler Herter, José Antônio de Azevedo Magalhães, Poli Mara Spritzer · 1996 · Journal of Clinical Ultrasound
86. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Stephen Franks · 2010 · Clinical Endocrinology
87. Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women
    Daniel Anthony Dumesic, David Howard Abbott, Joel Robert Eisner, Rebekah R. Herrmann, Judd E. Reed, Timothy J Welch, Michael D Jensen · 1998 · Fertility and Sterility
88. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
    David Cibula, Martin Hill, Michael Fanta, G Šindelka, Jaroslav Zivny · 2001 · Human Reproduction
89. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome
    Kalra, Pramila, Bansal, Beena, Nag, Piyal, Singh, Jitesh K., Gupta, Rakesh K., Kumar, Sunil, Rathore, Ram Kishore S., Bhatia, Vijayalakshmi, Bhatia, Eesh · 2009 · Fertility and Sterility
90. Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women
    Teraporn Vutyavanich, Vorathep Khaniyao, Supreeya Wongtra‐ngan · 2007 · Journal of obstetrics and gynaecology research
91. Vaniqa--eflornithine 13.9% cream.
    Jerry Shapiro, Lui H · 2001 · PubMed
92. Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome
    Gaetana Di Fede, Pasquale Mansueto, Rosa Alba Longo, GiovamBattista Rini, Enrico Carmina · 2008 · Fertility and Sterility
93. Acanthosis nigricans: Clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome
    Kandapa Charnvises, Sawaek Weerakiet, Yada Tingthanatikul, Surapee Wansumrith, Suwannee Chanprasertyothin, A Rojanasakul · 2005 · Gynecological Endocrinology
94. New recommendations on the safety of contraceptive methods for women with medical conditions: World Health Organization's Medical eligibility criteria for contraceptive use, fourth edition.
    Mary Eluned Gaffield, Kelly R. Culwell · 2010 · IPPF medical bulletin
95. The Suitability of Polycystic Ovary Syndrome-Specific Questionnaires for Measuring the Impact of PCOS on Quality of Life in Clinical Trials
    Aysha Malik-Aslam, Matthew D. Reaney, Jane Speight · 2010 · Value in Health
96. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome
    Amélio F. Godoy‐Matos, Fernanda Vaisman, Aline Pereira Pedrosa, Maria Lúcia Fleiuss Farias, Laura Maria Carvalho de Mendonça, Maria Fernanda Miguens Castelar Pinheiro · 2009 · Gynecological Endocrinology
97. Psychosocial aspects of women with polycystic ovary syndrome from south India.
    P. G. Sundararaman, Shweta ., Gumpeny Ramachandra Sridhar · 2008 · PubMed
98. The time has come to simplify the evaluation of the hirsute patient
    Ricardo Azziz · 2000 · Fertility and Sterility
99. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya: A Retrospective Study
    F.I. Najem, Rafik Ramadan Elmehdawi, A.M. Swalem · 2008 · Libyan Journal of Medicine
100. Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome
     Jana Vrbíková, Soňa Stanická, K Dvorakova, Martin Hill, K Vondra, Běla Bendlová, Luboslav Stárka · 2004 · European Journal of Endocrinology
101. Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
     Cheang, Kai I., Nestler, John E., Futterweit, Walter · 2008 · Endocrine Practice
102. Irregularidade do ciclo menstrual no menacme como marcador para fatores de risco cardiovasculares na pós-menopausa
     George Dantas de Azevedo, João Marcelo Brasil Pinheiro Duarte, M. O. Souza, Thiago D.N. Costa-e-Silva, Elvira Maria Mafaldo Soares, T.M.O. Maranhão · 2006 · Arquivos Brasileiros de Endocrinologia & Metabologia
103. Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome
     Heather Ilene Katcher, Allen R. Kunselman, Romana Dmitrović, Laurence M. Demers, Carol L. Gnatuk, Penny M. Kris‐Etherton, Richard S. Legro · 2008 · Fertility and Sterility
104. Risk of Atherosclerosis in Women with Polycystic Ovary Syndrome: A Study from South India
     P. G. Sundararaman, R. Manomani, Gumpeny Ramachandra Sridhar, Vishaal Sridhar, A. Sundaravalli, Meena Umachander · 2003 · Metabolic Syndrome and Related Disorders
105. Relationships among Serum Testosterone Levels, Body Fat and Muscle Mass Distribution in Women with Polycystic Ovary Syndrome.
     Tsutomu Douchi, Nobuyuki Yoshimitsu, Yukihiro Nagata · 2001 · Endocrine Journal
106. Diagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome
     Takeshi Iwasa, Toshiya Matsuzaki, Masahiro MINAKUCHI · 2007 · Endocrine Journal
107. Polycystic Ovary Syndrome in Asian Women
     Ernest Hung Yu Ng, Pak‐Leung Ho · 2008 · Seminars in Reproductive Medicine
108. Dietary effects on fertility treatment and pregnancy outcomes
     Siew S. Lim, Manny Noakes, Robert John Norman · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
109. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome
     Mary C. Taylor, A. Reema Kar, Allen R. Kunselman, Christy Stetter, Andrea Elizabeth Dunaif, Richard S. Legro · 2011 · Human Reproduction
110. Current Management of Polycystic Ovary Syndrome
     Adam H. Balen, Stephen Franks, Roy Homburg · 2010 · Cambridge University Press eBooks
111. Insulin Responses to the Oral Glucose Tolerance Test in Women of Different Ethnicity With Polycystic Ovary Syndrome
     Haya M Al-Fozan, Abdullah Al-Futaisi, David Morris, Togas Tulandi · 2005 · Journal of Obstetrics and Gynaecology Canada
112. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi-Libya; A Retrospective study
     F.I. Najem, Rafik Ramadan Elmehdawi, A.M. Swalem · 2008 · Libyan Journal of Medicine
113. The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome
     Moran, Lisa J., Noakes, Manny, Clifton, Peter M., Norman, Robert J. · 2010 · Fertility and Sterility
114. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels
     Thomas M. Barber, Amanda J. Bennett, Anna L. Gloyn, Christopher J. Groves, Ulla Sovio, Aimo Ruokonen, Hannu K. Martikainen, Anneli M. Pouta, Saara Taponen, Michael N. Weedon et al. · 2007 · European Journal of Human Genetics
115. Psychosocial and sociocultural aspects of infertility - a comparison between Austrian women and immigrant women
     Julia Schmid, Sylvia Kirchengast, Elisabeth Vytiska‐Binstorfer, Johannes C. Huber · 2004 · Anthropologischer Anzeiger
116. Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
     Peter Boyle, Harri Vainio, Robert Allen Smith · 2004 · Annals of Oncology
117. Optimal Waist Circumference for Prediction of Metabolic Syndrome in Young Korean Women With Polycystic Ovary Syndrome
     Jee Young Oh, Yeon‐Ah Sung, Hye Jin Lee, Ji Young Oh, Hye Won Chung, Hyesook Park · 2009 · Obesity
118. Sexual Dysfunction in Women With Polycystic Ovary Syndrome: The Effects of Testosterone, Obesity, and Depression
     Jennifer T. Anger, Ann J. Brown, Cindy L. Amundsen · 2007 · Journal of Pelvic Medicine and Surgery
119. Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report.
     Aleksandra Marciniak, Jolanta Nawrocka-Rutkowska, Agnieszka Brodowska, Robert Sienkiewicz, Iwona Szydłowska, Andrzej Starczewski · 2009 · Folia Histochemica et Cytobiologica
120. Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins
     Anders Nyboe Andersen, Adam H. Balen, Peter Platteau, G. Pettersson, Joan‐Carles Arce · 2010 · Human Reproduction
121. Polycystic ovary syndrome as a developmental disorder
     Angelique J. Goverde, Hendrika E. Westerveld, Susanne M. Veltman-Verhulst, Bart C.J.M. Fauser · 2008 · Expert Review of Obstetrics & Gynecology
122. Insulin resistance and upper-body obesity in polycystic ovary syndrome
     Ansam A. Al-Bayatti · 2007 · Bioline International (Bioline International)
123. Etiology of hirsutism. Is there a correlation between menstrual regularity, body mass index and severity of hirsutism with the cause?
     Farid–ur–Rehman, Irum Sohail, Zartaj Hayat · 2016 · Journal of Pakistan Association of Dermatologists
124. Management of polycystic ovary syndrome in postmenopausal women: a medical black hole
     Anna J. Fenton, Nick Panay · 2008 · Climacteric
125. Ethnic variations in the expression of polycystic ovary syndrome
     Chandrika N. Wijeyaratne, Vindya Kumarapeli, R. d. A. Seneviratne, Charles Antonypillai, Sanjeewa Seneviratne, Gj Chaminda Garusinghe, Senarath Yapa, Adam H. Balen · 2010 · Cambridge University Press eBooks
126. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome
     Amélio F. Godoy‐Matos, Fernanda Vaisman, Aline Pedrosa · 2009 · Gynecological Endocrinology